Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

Abstract Background Patients with both diabetes mellitus (DM) and chronic kidney disease (CKD) are a subpopulation characterized by ultrahigh ischemic and bleeding risk after percutaneous coronary intervention. There are limited data on the impact of ticagrelor monotherapy among these patients. Meth...

Full description

Bibliographic Details
Main Authors: Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, Hideyuki Kawashima, Rutao Wang, Hironori Hara, Masafumi Ono, Gilles Montalescot, Scot Garg, Michael Haude, Ton Slagboom, Pascal Vranckx, Marco Valgimigli, Stephan Windecker, Robert-Jan van Geuns, Christian Hamm, Philippe Gabriel Steg, Yoshinobu Onuma, Dominick J. Angiolillo, Patrick W. Serruys
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Cardiovascular Diabetology
Subjects:
Chronic kidney disease
Diabetes mellitus
Percutaneous coronary intervention
DAPT
Ticagrelor
Aspirin-free antiplatelet strategies
Online Access:http://link.springer.com/article/10.1186/s12933-020-01153-x

Internet

http://link.springer.com/article/10.1186/s12933-020-01153-x

Similar Items